Phibro Animal Health (NASDAQ:PAHC) Upgraded by StockNews.com to Strong-Buy Rating

StockNews.com upgraded shares of Phibro Animal Health (NASDAQ:PAHC) from a buy rating to a strong-buy rating in a research note released on Thursday morning.

Several other equities analysts have also issued reports on PAHC. JPMorgan Chase & Co. began coverage on shares of Phibro Animal Health in a report on Tuesday, September 10th. They set a “neutral” rating and a $22.00 price objective on the stock. Barclays boosted their price target on Phibro Animal Health from $13.00 to $20.00 and gave the stock an “underweight” rating in a research report on Tuesday, November 12th. Finally, Bank of America raised their price objective on Phibro Animal Health from $13.00 to $15.00 and gave the company an “underperform” rating in a research report on Friday, August 30th. Three analysts have rated the stock with a sell rating, one has assigned a hold rating and one has given a strong buy rating to the company. According to MarketBeat, the stock presently has an average rating of “Hold” and an average price target of $16.50.

Phibro Animal Health Stock Down 0.9 %

NASDAQ:PAHC opened at $23.37 on Thursday. The company has a debt-to-equity ratio of 1.81, a current ratio of 3.23 and a quick ratio of 1.69. The firm has a market cap of $946.49 million, a PE ratio of 54.35, a price-to-earnings-growth ratio of 0.60 and a beta of 0.51. The company has a 50-day moving average of $23.32 and a 200 day moving average of $20.23. Phibro Animal Health has a 1-year low of $9.49 and a 1-year high of $25.98.

Phibro Animal Health Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, December 18th. Stockholders of record on Wednesday, November 27th will be given a $0.12 dividend. The ex-dividend date is Wednesday, November 27th. This represents a $0.48 dividend on an annualized basis and a dividend yield of 2.05%. Phibro Animal Health’s payout ratio is 111.63%.

Insider Activity at Phibro Animal Health

In related news, Director E Thomas Corcoran bought 5,000 shares of the company’s stock in a transaction on Wednesday, September 4th. The shares were bought at an average price of $20.02 per share, with a total value of $100,100.00. Following the transaction, the director now owns 25,000 shares in the company, valued at approximately $500,500. This trade represents a 25.00 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 50.07% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently made changes to their positions in the stock. CWM LLC increased its position in shares of Phibro Animal Health by 89.8% in the 2nd quarter. CWM LLC now owns 2,188 shares of the company’s stock valued at $37,000 after acquiring an additional 1,035 shares during the period. nVerses Capital LLC acquired a new position in shares of Phibro Animal Health in the third quarter valued at about $70,000. Quantbot Technologies LP purchased a new position in shares of Phibro Animal Health in the third quarter worth about $70,000. Summit Securities Group LLC acquired a new stake in shares of Phibro Animal Health during the second quarter worth about $83,000. Finally, China Universal Asset Management Co. Ltd. boosted its position in Phibro Animal Health by 63.7% in the third quarter. China Universal Asset Management Co. Ltd. now owns 3,912 shares of the company’s stock valued at $88,000 after buying an additional 1,522 shares during the last quarter. Hedge funds and other institutional investors own 99.34% of the company’s stock.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.